Module 1 Flashcards
historical influences to pharmacology
- discoveries by ancient civilizations
- role of poisons
- influence of religion
ancient greece drug development
textbook on therapeutics including opium
opium obtained from opium poppy (pain relieving capabilities)
opium contains morphine (10%) and codeine (0.5%)
ancient egypt drug development
documents called papyri intended to be a textbook of drug use
observations of drug use specifically purgatives (cause bowel movement)
recommended drug was senna
ancient china drug development
classified drugs according to taste
ma huang (medium drug) used for coughs, influenza and fevers
modern era ephedrine isolated from ma huang and used to treat asthma, and a derivative of ephedrine used as a decongestant
curare (poison) drug development
plant derived drug used by indigenous people
used in hunting to paralyze animals and cause death
used by anaesthetists in surgery
ergot (poison) drug development
poisonous fungus growing on the heads of rye
was mixed with rye and found in bread causing epidemics
peyote religious use
peyote cactus causes mystical state (hallucinations, feeling of well being and distortion of perception) which was linked to spiritual and ritualistic use
broad definition of drugs
any substance received by a biological system that is not received for nutritive purposes and which influences the biological function of the organism
two major categories of drugs
- drugs that act on the brain
- drugs that act against infectious disease
drugs acting on the brain
dugs that alter normal chemical signalling in the brain
LSD is the most potent hallucinogenic drugs
LSD (lysergic acid diethlylamide)
synthesized by a albert hofmann in 1943
discovery support idea that certain mental illnesses may be due to production of potent substances in the brain causing psychic disturbance
classified as a controlled substance
evidence it may be effective in treating certain mental illnesses (depression, anxiety, addiction)
drugs acting against infectious disease
any disease caused by an organism
1900s
- drug to cure syphilis
1930s
- sulfa drugs to treat bacterial drugs
- now called antibiotics
1940s
- discovery of penicillin
- used in gram positive bacterial disease
1950s
- discovery of streptomycin
- treated tuberculosis and gram negative bacterial diseases
gram positive/negative bacterial disease
positive: bacteria with thick cell walls and no outer membrane
negative: bacteria with thin cell walls and an outer membrane
drug development process
- drug discovery (3-6 years)
- drug development (6-7 years)
drug discovery process
- basic research and drug discovery
- preclinical trials
drug development process
clinical trials
- phase 1 (10 patients)
- phase 2 (100s)
- phase 3 (1000s)
health canada review and manufacturing
post market surveillance and phase IV clinical trials
basic research and discovery
identification of target
- receptor that when activated causes relief or pain
- research about target to determine pharmacological effects at various levels
studying target
- compound with promise lead compound
- tests for efficacy and safety
efficacy definition
max pharmacological response that can be produced by a specific drug in a biological system
preclinical studies
tested in molecular / cellular studies, tissues and whole animal
pharmacology studies determines mechanisms of action of the drug
toxicology studies potential risks or harmful effects of the drug (expensive)
clinical trials initial steps
- proof of safety in several animal species
- proposed methodology
- submission evaluated by scientists and permission given to investigate
phase 1 clinical trials
evaluate absorption, distribution, elimination and adverse effects of drug
test one of two doses of the drug to test tolerability
conducted on healthy volunteers (20-80)
phase 2 clinical trials
determine if the drug is effective and evaluates safety
conducted with patients with disease drug is treating
phase 3 clinical trials
large number 1000+ and multi centred (dif locations)
determine how safe and effective drug is compared to no treatment (placebo) or current therapy
longer than phase 2 (months to years)
most expensive (1-50 million)
design of phase 3 clinical trials
- determining enrolment prior
- allocating participants to treatment groups and conducting the trial
- monitoring and analyzing results
phase 3 enrolment
people drug is tested on needs to be defined
target population group of patients the drug is intended for
inclusion/exclusion criteria + consent
phase 3 treatment allocation
double blinded, investigator nor study subject aware of treatment the study subject is assigned to (randomization)
treatment or control (placebo or gold standard)
bias can occur if subject believe drug will work or investigator expects positive results lead to bias results
phase 3 results
determines if the treatment was more or less effective than the control
outcome of the trial that measures effectiveness and compares it (objective and reliable manner)
compliance, quality or life and statistics
drug patent and naming
manufactures come up with a drug name (generic) and a brand name for the drug
patent gives company exclusive rights to market the drug for 20 years (filed during preclinical development)
drug bioqeuivlence
strict regulations in place to ensure all market drugs are as effective as the original brand name drug and are bio equivalent (same ingredients and give similar blood levels)
comparative bioavailability study conducted to compare blood levels in healthy volunteers
phase 4 clinical trials
delayed or less frequent risks missed so surveillance of effects needed
post marketing surveillance
placebo definition
substance masquerading as a drug
identical in appearance, colour, taste and administration method to active drug
drug action factors
- drug target
- drug response
- efficacy and potency
- therapeutic range
drug targets
usually receptors, also interact non specifically with biological system
many receptors exist and are distributed through body, location determines where drug acts and if response is beneficial or detrimental
opioid receptors activation
activation in brain causes pain relief
activation in gastrointestinal tract causes constipation (adverse effect)
drug target chemical reactions/forces
antacids neutralize stomach acid through acid base neutralization reaction
cholestyramine binds to bile acids in gastrointestinal tract preventing reabsorption and increasing elimination of bile salts used to make cholesterol
drugs and receptors
drugs mimic action or block effects of ligands at the receptors
agonists stimulate receptor
antagonists block receptor
drug response
intensity of effects by a drug increases in proportion to dose (dose response relationship)
factors when comparing drugs
- quantity
- frequency of use
- user demographic
- environmental factors
dose amounts and effects
low dose, little response observed as few receptor activated
threshold, effect seen as more receptor activated
therapeutic dose, threshold reached small increased results in large increase response
maximal effect, once max is reached increasing amount will have no increase in therapeutic response
effective dose
ED50 - dose that is effective in 50% of population
result in 50% of maximal effect
efficacy
max pharmacological response produced by a specific drug in that biological system
potency
dose of drug required to produce a response of a certain magnitude
usually 50% maximal response
therapeutic range
dose that keeps blood concentration of a drug above the minimum concentration that produces desirable response but below concentration that produced unacceptable toxicity
pharmacokinetic
refers to movement of a drug into, through and out of the body
for a drug to produced desired effect is must reach cellular site of action at the right concentration, exert its effect and then be removed from the body
administrations of drugs
- topical
- enteral
- patenteral
processes after administration
ADME
- absorption
- distribution
- metabolism
- excretion
factors determine concentration of drug in blood which determines concentration of drug at the site of action
topical administration
applied directly to particular place on or in the body
- on skin
- through skin
- inhalation